0001061983-17-000056.txt : 20170908
0001061983-17-000056.hdr.sgml : 20170908
20170908164802
ACCESSION NUMBER: 0001061983-17-000056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170906
FILED AS OF DATE: 20170908
DATE AS OF CHANGE: 20170908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McDowell Caryn Gordon
CENTRAL INDEX KEY: 0001674232
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50633
FILM NUMBER: 171077059
MAIL ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYTOKINETICS INC
CENTRAL INDEX KEY: 0001061983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943291317
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
STREET 2: .
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 624-3000
MAIL ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-09-06
0
0001061983
CYTOKINETICS INC
CYTK
0001674232
McDowell Caryn Gordon
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
GC & Chief Compliance Officer
Common Stock
2017-09-06
4
M
0
1432
6.67
A
19801
D
Common Stock
2017-09-06
4
S
0
200
14.1
D
19601
D
Common Stock
2017-09-06
4
M
0
3067
6.67
A
22668
D
Common Stock
2017-09-06
4
S
0
200
14.15
D
22468
D
Common Stock
2017-09-06
4
M
0
5732
6.37
A
28200
D
Common Stock
2017-09-06
4
S
0
898
14.2
D
27302
D
Common Stock
2017-09-06
4
S
0
400
14.25
D
26902
D
Common Stock
2017-09-06
4
S
0
100
14.275
D
26802
D
Common Stock
2017-09-06
4
S
0
302
14.3
D
26500
D
Common Stock
2017-09-06
4
S
0
200
14.35
D
26300
D
Common Stock
2017-09-06
4
S
0
200
14.375
D
26100
D
Common Stock
2017-09-06
4
S
0
400
14.4
D
25700
D
Common Stock
2017-09-06
4
S
0
600
14.45
D
25100
D
Common Stock
2017-09-06
4
S
0
200
14.475
D
24900
D
Common Stock
2017-09-06
4
S
0
200
14.5
D
24700
D
Common Stock
2017-09-06
4
S
0
200
14.525
D
24500
D
Common Stock
2017-09-06
4
S
0
200
14.575
D
24300
D
Common Stock
2017-09-06
4
S
0
700
14.6
D
23600
D
Common Stock
2017-09-06
4
S
0
300
14.625
D
23300
D
Common Stock
2017-09-06
4
S
0
200
14.65
D
23100
D
Common Stock
2017-09-06
4
S
0
500
14.7
D
22600
D
Common Stock
2017-09-06
4
S
0
200
14.725
D
22400
D
Common Stock
2017-09-06
4
S
0
600
14.75
D
21800
D
Common Stock
2017-09-06
4
S
0
400
14.775
D
21400
D
Common Stock
2017-09-06
4
S
0
400
14.8
D
21000
D
Common Stock
2017-09-06
4
S
0
100
14.825
D
20900
D
Common Stock
2017-09-06
4
S
0
724
14.85
D
20176
D
Common Stock
2017-09-06
4
S
0
600
14.9
D
19576
D
Common Stock
2017-09-06
4
S
0
400
14.925
D
19176
D
Common Stock
2017-09-06
4
S
0
707
14.95
D
18469
D
The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.
Caryn McDowell
2017-09-08